On Friday, Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $1.34 which represents a slight increase of $0.01 or 0.75% from the prior close of $1.33. The stock opened at $1.
Bank First (NASDAQ:BFC – Get Free Report) had its price target increased by Piper Sandler from $99.00 to $104.00 in a note issued to investors on Thursday, Marketbeat reports. The firm presently has a ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.04% of ...